THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL
批准号:
7526460
负责人:
Patrick M Stuart
金额:
$35.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-09-29
关键词:
ApoptosisApoptoticBlindnessCellsCessation of lifeCicatrixCommunicable DiseasesCorneaCorneal DiseasesCountryDataDevelopmentDiseaseEyeEye diseasesGenesGenomeGrowthHerpesvirus 1Herpetic KeratitisHumanImmuneInbred BALB C MiceIncidenceInfectionInflammationInflammatory ResponseKeratitisKeratoplastyLaboratoriesLeadLuciferasesLymphoid CellMaintenanceManuscriptsMediatingModelingMonitorMouse StrainsMusMutant Strains MiceMutationNervous system structureNeuronsPeripheralPlayPreventionPublishingRecurrenceReportingRoleSimplexvirusStructure of trigeminal ganglionT-LymphocyteTNFRSF6 geneTestingTissuesTumor Necrosis Factor Ligand Superfamily Member 6United StatesViralVirusVirus DiseasesVirus LatencyVirus SheddingWild Type MouseWorkcell typecorneal allograftdesigndisease phenotypeirradiationmacrophagemutantneovascularizationneuropathologyneutrophilocular surfacepreventpublic health relevancesuccesstrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our laboratory has been studying the role that Fas and Fas ligand play in corneal transplantation and have published several manuscripts detailing the importance of this interaction to the success of corneal allografts and the prevention of neovascularization of the cornea. However, the role that these apoptotic molecules play in herpetic eye disease remains to be fully delineated. The only report on this subject used a virus-mouse strain combination that does not produce significant disease. Thus the precise role that apoptotic molecules play in either causing or preventing HSV-1-mediated ocular disease is not clear. In order to bring more clarity to this situation, we performed preliminary studies wherein we infected BALB/c, and BALB-lpr (Fas mutants), and BALB-gld (Fas Ligand mutants) mice with the KOS strain of HSV-1 as well as C57BL/6 and its mutants with the McKrae strain of HSV-1, and monitored both corneal disease and shedding of virus from the ocular surface. Our observations indicate that mice that express a mutation in the Fas (CD95) gene had significantly worse HSK, and periocular disease, than did either wild type BALB/c or B6 mice. Gld mutants of these mouse strains were either no different than wild-type (BALB/c) or displayed an intermediated disease phenotype. Preliminary results also suggest that virus might persist in peripheral tissues slightly longer in BALB-lpr mice than in wild type controls, but similar persistence is also noted in BALB-gld mice. Suggesting that the disease phenotype in lpr mice might is not simply due to viral persistence, but that other mechanisms are involved. In order to better define the role that apoptotic molecules have during herpetic stromal keratitis we propose: To determine the specific contributions of Fas and FasL to ocular disease, protection from neuropathology, growth of virus, and maintenance of viral latency. Secondly, since we know that recurrent eye disease is not the same as primary HSK, we will perform similar studies in a recurrent model of HSK to evaluate the role of Fas and FasL in this form of the disease. We will also explore the efficacy of treating mice with a soluble form of Fas ligand as a means of more effectively controlling HSV-1 initiated inflammation. We believe these studies will enable us to better understand the role that the Fas-Fas ligand interaction plays during infectious disease of the cornea. PUBLIC HEALTH RELEVANCE The studies in this application are designed to better understand what mechanisms are involved in controlling the entry of immune cells (inflammation) into the cornea following infection with herpes simplex virus. This is important because the more inflammation that occurs the worse will be damage to the cornea. In addition, we will test a potential therapy that is designed to further control and possibly prevent inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of HSK amelioration
-
批准号:8389553
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
Mechanisms of HSK amelioration
-
批准号:8597431
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
Mechanisms of HSK amelioration
-
批准号:8026561
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
Mechanisms of HSK amelioration
-
批准号:8207849
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL
-
批准号:7935224
-
项目类别:
-
资助金额:$34.44万
-
财政年份:2009
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6384835
-
项目类别:
-
资助金额:$32.37万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:2899161
-
项目类别:
-
资助金额:$27.25万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6179299
-
项目类别:
-
资助金额:$26.94万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6951737
-
项目类别:
-
资助金额:$5.36万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6414277
-
项目类别:
-
资助金额:$6.49万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6524983
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6637194
-
项目类别:
-
资助金额:$29.44万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
AMELIORATION OF RECURRENT HERPES KERATITIS
-
批准号:6384708
-
项目类别:
-
资助金额:$22.92万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:6617615
-
项目类别:
-
资助金额:$37.08万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:6751542
-
项目类别:
-
资助金额:$36.12万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:6895084
-
项目类别:
-
资助金额:$37.31万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:7059913
-
项目类别:
-
资助金额:$37.63万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:7233139
-
项目类别:
-
资助金额:$38.64万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
AMELIORATION OF RECURRENT HERPES KERATITIS
-
批准号:6179213
-
项目类别:
-
资助金额:$22.41万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
IA INDUCTION/EXPRES'N IN NON-BONE MARROW-DERIVED CELLS
-
批准号:3029218
-
项目类别:
-
资助金额:$2.93万
-
财政年份:1989
-
负责人:Patrick M Stuart
-
依托单位:
海外基金